| Trial ID: | L0685 |
| Source ID: | NCT02228655
|
| Associated Drug: |
Fmx-8
|
| Title: |
An Exploratory Study to Evaluate FMX-8 to Treat Anemia in CKD
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Anemia in Chronic Kidney Disease
|
| Interventions: |
DRUG: FMX-8
|
| Outcome Measures: |
Primary: Change in hemoglobin concentration, 57 day evaluation period |
|
| Sponsor/Collaborators: |
Sponsor: FerruMax Pharmaceuticals, Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
EARLY_PHASE1
|
| Enrollment: |
2
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2014-10
|
| Completion Date: |
2015-07
|
| Results First Posted: |
|
| Last Update Posted: |
2016-02-02
|
| Locations: |
Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02228655
|
